Reuters logo
BRIEF-Aap Implantate will not achieve previous FY 2016 sales and EBITDA forecast for continued operation
December 15, 2016 / 9:49 AM / 9 months ago

BRIEF-Aap Implantate will not achieve previous FY 2016 sales and EBITDA forecast for continued operation

Dec 15 (Reuters) - Aap Implantate AG :

* aap updates forecast for financial year 2016 due to delays in sales development in various markets

* Announces that it will not achieve previous sales and EBITDA forecast for financial year 2016 for continued operation

* Adjusts its forecast for financial year 2016 for continued operation and now anticipates sales between 11.0 million euros and 12.1 million euros ($12.71 million)as well as an EBITDA of -7.5 million to -7.0 million euros

* For 2016 EBITDA of group (continued and discontinued operation including deconsolidation profit from sale of aap biomaterials gmbh) company anticipates a value of between 16.5 million and 17.0 million euros

* Management board aims at a ce approval and closing of a license deal in financial year 2017 which will have visible influence on financial figures

* Reasons for this adjustment are delays in sales development in various markets leading to a sales shift in financial year 2017 Source text for Eikon: Further company coverage: ($1 = 0.9523 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below